Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "net-profit"

577 News Found

Alkem reports 7.1% YoY revenue growth in Q4 FY25
News | May 30, 2025

Alkem reports 7.1% YoY revenue growth in Q4 FY25

Annual EBITDA margin expands by 170 basis points


Sun Pharma Q4 FY25 revenue up 8.5% to Rs. 12,815 Cr
News | May 27, 2025

Sun Pharma Q4 FY25 revenue up 8.5% to Rs. 12,815 Cr

Net profit for the?quarter came in at Rs. 2,889.1 crore, up 4.8 per cent from the year earlier, adjusted for exceptional items


Torrent Pharma reports Q4 FY25 PAT at Rs. 498 Cr
News | May 26, 2025

Torrent Pharma reports Q4 FY25 PAT at Rs. 498 Cr

The revenue witnessed a growth of 7.80 per cent on a year-on-year basis at Rs. 2,959 crore


Gland Pharma Q4 FY25 PAT falls to Rs. 186.5 Cr
News | May 26, 2025

Gland Pharma Q4 FY25 PAT falls to Rs. 186.5 Cr

R&D spend for Q4 was Rs. 50.3 crore, 4.9 per cent of Q4?revenue


Cupid posts Q4 FY25 consolidated PAT at Rs. 11.51 Cr
News | May 22, 2025

Cupid posts Q4 FY25 consolidated PAT at Rs. 11.51 Cr

The company has posted net profit of Rs. 40.88 crores for the Financial Year ended March 31, 2025


Mankind Pharma posts Q4 FY25 consolidated PAT Rs. 425.11 Cr
News | May 22, 2025

Mankind Pharma posts Q4 FY25 consolidated PAT Rs. 425.11 Cr

The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025


Global Health posts Q4 FY25 consolidated PAT at Rs. 101.4 Cr
News | May 20, 2025

Global Health posts Q4 FY25 consolidated PAT at Rs. 101.4 Cr

Global Health has posted net profit of Rs. 481.43 crores for the Financial Year ended March 31, 2025


Alivus Life Sciences reports Q4 FY25 PAT at Rs. 141.86 Cr
News | May 18, 2025

Alivus Life Sciences reports Q4 FY25 PAT at Rs. 141.86 Cr

The company has posted net profit of Rs. 485.62 crores for the Financial Year ended March 31, 2025


Wanbury posts Q4 FY25 consolidated PAT at Rs. 20.25 Cr
News | May 18, 2025

Wanbury posts Q4 FY25 consolidated PAT at Rs. 20.25 Cr

The company has posted net profit of Rs. 30.53 crores for the Financial Year ended March 31, 2025


Solara Active Pharma Sciences posts Q4 FY25 consolidated loss at Rs. 2.10 Cr
News | May 18, 2025

Solara Active Pharma Sciences posts Q4 FY25 consolidated loss at Rs. 2.10 Cr

The company has posted net profit of Rs. 0.54 crores for the Financial Year ended March 31, 2025